vs
MIMEDX GROUP, INC.（MDXG）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
MIMEDX GROUP, INC.的季度营收约是PDF SOLUTIONS INC的1.9倍（$118.1M vs $62.4M），MIMEDX GROUP, INC.净利率更高（12.9% vs -0.1%，领先12.9%），MIMEDX GROUP, INC.同比增速更快（27.1% vs 24.6%），过去两年PDF SOLUTIONS INC的营收复合增速更高（22.9% vs 18.1%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
MDXG vs PDFS — 直观对比
营收规模更大
MDXG
是对方的1.9倍
$62.4M
营收增速更快
MDXG
高出2.5%
24.6%
净利率更高
MDXG
高出12.9%
-0.1%
两年增速更快
PDFS
近两年复合增速
18.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $62.4M |
| 净利润 | $15.2M | $-48.0K |
| 毛利率 | 83.9% | 72.9% |
| 营业利润率 | 17.8% | 5.5% |
| 净利率 | 12.9% | -0.1% |
| 营收同比 | 27.1% | 24.6% |
| 净利润同比 | 104.2% | -108.9% |
| 每股收益（稀释后） | $0.10 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGPDFS
| Q4 25 | $118.1M | $62.4M | ||
| Q3 25 | $113.7M | $57.1M | ||
| Q2 25 | $98.6M | $51.7M | ||
| Q1 25 | $88.2M | $47.8M | ||
| Q4 24 | $92.9M | $50.1M | ||
| Q3 24 | $84.1M | $46.4M | ||
| Q2 24 | $87.2M | $41.7M | ||
| Q1 24 | $84.7M | $41.3M |
净利润MDXGPDFS
| Q4 25 | $15.2M | $-48.0K | ||
| Q3 25 | $16.7M | $1.3M | ||
| Q2 25 | $9.6M | $1.1M | ||
| Q1 25 | $7.0M | $-3.0M | ||
| Q4 24 | $7.4M | $539.0K | ||
| Q3 24 | $8.1M | $2.2M | ||
| Q2 24 | $17.6M | $1.7M | ||
| Q1 24 | $9.3M | $-393.0K |
毛利率MDXGPDFS
| Q4 25 | 83.9% | 72.9% | ||
| Q3 25 | 83.5% | 72.3% | ||
| Q2 25 | 81.1% | 71.2% | ||
| Q1 25 | 81.2% | 72.9% | ||
| Q4 24 | 81.8% | 68.3% | ||
| Q3 24 | 81.8% | 73.1% | ||
| Q2 24 | 83.0% | 70.6% | ||
| Q1 24 | 84.7% | 67.3% |
营业利润率MDXGPDFS
| Q4 25 | 17.8% | 5.5% | ||
| Q3 25 | 19.5% | 8.5% | ||
| Q2 25 | 12.5% | 2.2% | ||
| Q1 25 | 9.4% | -7.4% | ||
| Q4 24 | 11.9% | 1.0% | ||
| Q3 24 | 13.3% | 4.6% | ||
| Q2 24 | 26.9% | 0.6% | ||
| Q1 24 | 15.6% | -4.7% |
净利率MDXGPDFS
| Q4 25 | 12.9% | -0.1% | ||
| Q3 25 | 14.7% | 2.3% | ||
| Q2 25 | 9.8% | 2.2% | ||
| Q1 25 | 8.0% | -6.3% | ||
| Q4 24 | 8.0% | 1.1% | ||
| Q3 24 | 9.6% | 4.8% | ||
| Q2 24 | 20.2% | 4.1% | ||
| Q1 24 | 10.9% | -1.0% |
每股收益（稀释后）MDXGPDFS
| Q4 25 | $0.10 | $0.00 | ||
| Q3 25 | $0.11 | $0.03 | ||
| Q2 25 | $0.06 | $0.03 | ||
| Q1 25 | $0.05 | $-0.08 | ||
| Q4 24 | $0.05 | $0.01 | ||
| Q3 24 | $0.05 | $0.06 | ||
| Q2 24 | $0.12 | $0.04 | ||
| Q1 24 | $0.06 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $42.2M |
| 总债务越低越好 | $18.0M | $67.0M |
| 股东权益账面价值 | $256.5M | $271.0M |
| 总资产 | $342.7M | $418.7M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资MDXGPDFS
| Q4 25 | $166.1M | $42.2M | ||
| Q3 25 | $142.1M | $35.9M | ||
| Q2 25 | $118.9M | $40.4M | ||
| Q1 25 | $106.4M | $54.1M | ||
| Q4 24 | $104.4M | $114.9M | ||
| Q3 24 | $88.8M | $120.2M | ||
| Q2 24 | $69.0M | $117.9M | ||
| Q1 24 | $48.5M | $122.9M |
总债务MDXGPDFS
| Q4 25 | $18.0M | $67.0M | ||
| Q3 25 | — | $67.6M | ||
| Q2 25 | — | $68.1M | ||
| Q1 25 | — | $68.7M | ||
| Q4 24 | $19.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDXGPDFS
| Q4 25 | $256.5M | $271.0M | ||
| Q3 25 | $238.9M | $264.4M | ||
| Q2 25 | $216.6M | $257.5M | ||
| Q1 25 | $202.8M | $249.0M | ||
| Q4 24 | $193.1M | $246.0M | ||
| Q3 24 | $181.0M | $240.5M | ||
| Q2 24 | $168.0M | $232.2M | ||
| Q1 24 | $155.7M | $225.4M |
总资产MDXGPDFS
| Q4 25 | $342.7M | $418.7M | ||
| Q3 25 | $319.0M | $406.4M | ||
| Q2 25 | $291.1M | $391.1M | ||
| Q1 25 | $270.4M | $390.0M | ||
| Q4 24 | $263.9M | $315.3M | ||
| Q3 24 | $243.9M | $307.4M | ||
| Q2 24 | $230.2M | $298.0M | ||
| Q1 24 | $221.7M | $286.8M |
负债/权益比MDXGPDFS
| Q4 25 | 0.07× | 0.25× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $17.3M |
| 自由现金流经营现金流 - 资本支出 | — | $7.5M |
| 自由现金流率自由现金流/营收 | — | 12.1% |
| 资本支出强度资本支出/营收 | — | 15.7% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.6M |
8季度趋势，按日历期对齐
经营现金流MDXGPDFS
| Q4 25 | $25.0M | $17.3M | ||
| Q3 25 | $29.3M | $3.3M | ||
| Q2 25 | $14.4M | $-5.2M | ||
| Q1 25 | $5.3M | $8.6M | ||
| Q4 24 | $18.8M | $1.6M | ||
| Q3 24 | $19.6M | $9.3M | ||
| Q2 24 | $21.8M | $684.0K | ||
| Q1 24 | $6.0M | $-1.9M |
自由现金流MDXGPDFS
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | $-2.9M | ||
| Q2 25 | — | $-13.8M | ||
| Q1 25 | — | $535.0K | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $-3.9M |
自由现金流率MDXGPDFS
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | -5.1% | ||
| Q2 25 | — | -26.6% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | -8.0% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | — | -11.1% | ||
| Q1 24 | — | -9.4% |
资本支出强度MDXGPDFS
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 10.8% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 4.9% |
现金转化率MDXGPDFS
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | 2.54× | ||
| Q2 25 | 1.50× | -4.55× | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | 2.98× | ||
| Q3 24 | 2.42× | 4.20× | ||
| Q2 24 | 1.24× | 0.40× | ||
| Q1 24 | 0.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
